Lymphedema following cancer therapy: overview and options

This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & experimental metastasis 2018-08, Vol.35 (5-6), p.547-551
Main Authors: Bernas, Michael, Thiadens, Saskia R. J., Smoot, Betty, Armer, Jane M., Stewart, Paula, Granzow, Jay
Format: Article
Language:English
Subjects:
Abnormalities
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer Research
Cancer therapies
Genetics
Health care
Health Personnel
Hematology
Humans
Lymphatic system
Lymphatic System - pathology
Lymphedema
Lymphedema - diagnosis
Lymphedema - etiology
Lymphedema - pathology
Lymphedema - therapy
Medical personnel
Metastases
Neoplasms - complications
Neoplasms - pathology
Neoplasms - therapy
Oncology
Patients
Physicians
Rehabilitation
Research Paper
Surgical instruments
Surgical Oncology
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.
ISSN:0262-0898
1573-7276
DOI:10.1007/s10585-018-9899-5